المؤلفون: Grever M; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu., Andritsos L; Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Anghelina M; Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Arons E; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Banerji V; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, and Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada., Barrientos J; Mount Sinai Medical Center Miami, Miami, FL, USA., Bhat SA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Blachly J; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Broccoli A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy., Call T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dearden C; The Royal Marsden NHS Foundation Trust, London, UK., Dietrich S; University Hospital of Düsseldorf, Düsseldorf, Germany., Else M; The Institute of Cancer Research, London, UK., Epperla N; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Fagarasanu A; University of Alberta, Edmonton, AB, Canada., Falini B; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Forconi F; Cancer Sciences and Haematology Department, University of Southampton and Cancer Care, Haematology Department, Southampton NHS University Hospital Trust, Southampton, UK., Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena Policlinico S Maria alle Scotte, Siena, Italy., Hampel P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hermel DJ; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Iyengar S; The Royal Marsden NHS Foundation Trust, London, UK., Johnston JB; Department of Medicine, University of Manitoba, Winnipeg, MB, Canada., Juliusson G; Lund University/Dept of Hematology, Skåne University Hospital, Lund, Sweden., Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Lauria F; University of Siena, Siena, Italy., Lozanski G; Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA., Oakes CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Park J; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Quest G; Pathology and Molecular Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada., Rai K; Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robak T; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Rogers KA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Saven A; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, VIC, Australia., Tadmor T; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Tallman MS; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia., Tiacci E; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Troussard X; Department of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France., Wörmann B; The Charité - Universitätsmedizin, Berlin, Germany., Zent CS; James P. Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Zenz T; Dept. of Medical Oncology & Haematology, Univerity Hospital and University of Zurich; The LOOP Zurich - Medical Research Center, Zurich, Switzerland., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy.

المصدر: Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1642-1644. Date of Electronic Publication: 2024 Jun 08.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/pathology , Leukemia, Hairy Cell*/classification , Leukemia, Hairy Cell*/diagnosis , World Health Organization*, Humans

المؤلفون: Ebrahimi A; Department of Internal Medicine, Scripps Clinic and Scripps Green Hospital, La Jolla, California, USA., Cham J; Department of Internal Medicine, Scripps Clinic and Scripps Green Hospital, La Jolla, California, USA., Puglisi L; Scripps Whittier Diabetes Institute, Scripps Health, San Diego, California, USA., De Shadarevian M; Department of Internal Medicine, Scripps Mercy Hospital, San Diego, California, USA., Hermel DJ; Department of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, California, USA., Spierling Bagsic SR; Scripps Whittier Diabetes Institute, Scripps Health, San Diego, California, USA., Sigal D; Department of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, California, USA.

المصدر: Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10243-10253. Date of Electronic Publication: 2023 Mar 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Adenocarcinoma*/pathology , Carcinoma, Pancreatic Ductal*/pathology , Lung Neoplasms*, Humans ; Prognosis ; Lung/pathology ; Retrospective Studies

المؤلفون: Hermel DJ; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson, 10666 N. Torrey Pines Ave, La Jolla, CA, 92037, USA. hermel.david@scrippshealth.org., Cheng B; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson, 10666 N. Torrey Pines Ave, La Jolla, CA, 92037, USA., Bhangoo MS; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson, 10666 N. Torrey Pines Ave, La Jolla, CA, 92037, USA., Burian C; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson, 10666 N. Torrey Pines Ave, La Jolla, CA, 92037, USA., Waalen J; Scripps Research Translational Institute, La Jolla, CA, USA., Saven A; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson, 10666 N. Torrey Pines Ave, La Jolla, CA, 92037, USA.

المصدر: Annals of hematology [Ann Hematol] 2022 May; Vol. 101 (5), pp. 1089-1096. Date of Electronic Publication: 2022 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Leukemia, Hairy Cell*/pathology, Aged ; Cladribine/therapeutic use ; Humans ; Remission Induction ; Retrospective Studies

المؤلفون: Hermel DJ; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Cham J; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Spierling Bagsic SR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Hong LK; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Costantini CL; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Mason JR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Saven A; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Sigal DS; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2022 Feb; Vol. 18 (6), pp. 719-725. Date of Electronic Publication: 2022 Feb 02.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*complications , COVID-19/*mortality , Neoplasms/*complications , Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; California/epidemiology ; Female ; Hospitalization ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunologic Factors/therapeutic use ; Lung Neoplasms/complications ; Male ; Middle Aged ; Molecular Targeted Therapy ; Patient Acuity ; Retrospective Studies ; SARS-CoV-2

المؤلفون: Sigal DS; Director, GI Oncology, Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, La Jolla, CA 92037, USA., Hermel DJ; Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, LA Jolla, CA 92037, USA., Hsu P; Medical Advisor, Medical Affairs & Clinical Development, OBI Pharma Inc. 7F, No. 369, Zhongxiao E Road, Nangang District, Taipei City, 115, Taiwan., Pearce T; Chief Medical Officer, OBI Pharma USA Inc., 6020 Cornerstone Court W, Suite 200, San Diego, CA 92121, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2022 Jan; Vol. 18 (1), pp. 117-134. Date of Electronic Publication: 2021 Nov 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Tumor-Associated, Carbohydrate/*physiology , Neoplasms/*etiology , Stage-Specific Embryonic Antigens/*physiology, Antigens, Tumor-Associated, Carbohydrate/immunology ; Cancer Vaccines/therapeutic use ; Embryonic Development ; Glycoconjugates/physiology ; Glycosphingolipids/antagonists & inhibitors ; Glycosphingolipids/physiology ; Humans ; Neoplasms/immunology ; Neoplasms/therapy ; Stage-Specific Embryonic Antigens/immunology

المؤلفون: Hermel DJ; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Spierling Bagsic SR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Costantini CL; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Mason JR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Gahvari ZJ; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Saven A; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA.

المصدر: Future science OA [Future Sci OA] 2021 Jun 12; Vol. 7 (8), pp. FSO735. Date of Electronic Publication: 2021 Jun 12 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Science Group Country of Publication: England NLM ID: 101665030 Publication Model: eCollection Cited Medium: Print ISSN: 2056-5623 (Print) Linking ISSN: 20565623 NLM ISO Abbreviation: Future Sci OA Subsets: PubMed not MEDLINE

المؤلفون: In GK; USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, NTT 3449, Los Angeles, CA, 90033, USA. gino.in@med.usc.edu.; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA. gino.in@med.usc.edu.; Department of Medicine, USC Keck School of Medicine, Los Angeles, CA, USA. gino.in@med.usc.edu., Vaidya P; Department of Medicine, USC Keck School of Medicine, Los Angeles, CA, USA., Filkins A; Department of Medicine, USC Keck School of Medicine, Los Angeles, CA, USA., Hermel DJ; Division of Hematology/Oncology, Scripps Clinic, La Jolla, CA, USA., King KG; Department of Radiology, USC Keck School of Medicine, Los Angeles, CA, USA., Ragab O; Department of Radiation Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Tseng WW; Department of Surgery, Division of Breast, Endocrine and Soft Tissue Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., Swanson M; Caruso Department of Otolaryngology-Head and Neck Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., Kokot N; Caruso Department of Otolaryngology-Head and Neck Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., Lang JE; Department of Surgery, Division of Breast, Endocrine and Soft Tissue Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., Menendez L; Department of Orthopaedic Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., DeClerck B; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA.; Department of Pathology, USC Keck School of Medicine, Los Angeles, CA, USA., Kim G; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA.; Department of Pathology, USC Keck School of Medicine, Los Angeles, CA, USA., Hu JC; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA., Terando A; Department of Surgery, Division of Breast, Endocrine and Soft Tissue Surgery, USC Keck School of Medicine, Los Angeles, CA, USA., Jadvar H; Department of Radiology, USC Keck School of Medicine, Los Angeles, CA, USA., Ricker C; USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, NTT 3449, Los Angeles, CA, 90033, USA., Miller KA; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA.; Department of Preventive Medicine, USC Keck School of Medicine, Los Angeles, CA, USA., Peng DH; Department of Dermatology, USC Keck School of Medicine, Los Angeles, CA, USA., Wysong A; Department of Dermatology, University of Nebraska Medical Center, Omaha, NE, USA.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Jun; Vol. 147 (6), pp. 1803-1811. Date of Electronic Publication: 2020 Nov 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell/*drug therapy , Immune Checkpoint Inhibitors/*therapeutic use , Skin Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; California/epidemiology ; Carcinoma, Squamous Cell/diagnosis ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Progression-Free Survival ; Retrospective Studies ; Skin Neoplasms/diagnosis ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Treatment Outcome ; Young Adult

المؤلفون: Hermel DJ; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Du EZ; Division of Pathology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Lin R; Division of Radiation Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Frenette CT; Division of Gastroenterology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Sigal DS; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA.

المصدر: Journal of clinical and translational hepatology [J Clin Transl Hepatol] 2021 Apr 28; Vol. 9 (2), pp. 265-268. Date of Electronic Publication: 2021 Feb 01.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Xia & He Publishing Inc Country of Publication: United States NLM ID: 101649815 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2225-0719 (Print) Linking ISSN: 22250719 NLM ISO Abbreviation: J Clin Transl Hepatol Subsets: PubMed not MEDLINE

المؤلفون: Karabachev AD; Department of Medicine, University of Vermont, Larner College of Medicine, Burlington, Vermont, United States of America., Martini DJ; Department of Medicine, University of Vermont, Larner College of Medicine, Burlington, Vermont, United States of America., Hermel DJ; Department of Medicine, University of Vermont, Larner College of Medicine, Burlington, Vermont, United States of America., Solcz D; Department of Medicine, University of Vermont, Larner College of Medicine, Burlington, Vermont, United States of America., Richardson ME; Ambry Genetics, Aliso Viejo, California, United States of America., Pesaran T; Ambry Genetics, Aliso Viejo, California, United States of America., Sarkar IN; Center for Biomedical Informatics, Brown University, Providence, Rhode Island, United States of America.; Rhode Island Quality Institute, Providence, Rhode Island, United States of America., Greenblatt MS; Department of Medicine, University of Vermont, Larner College of Medicine, Burlington, Vermont, United States of America.

المصدر: PloS one [PLoS One] 2020 Aug 04; Vol. 15 (8), pp. e0233673. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Genes, APC* , Mutation, Missense*, Adenomatous Polyposis Coli/*genetics , Adenomatous Polyposis Coli Protein/*genetics, Algorithms ; Amino Acid Sequence ; Computational Biology/methods ; Computer Simulation ; Databases, Protein ; Enhancer Elements, Genetic ; Evolution, Molecular ; Exons ; Genetic Variation ; Humans ; Phylogeny ; Protein Isoforms/genetics ; RNA Splice Sites ; Sequence Alignment/statistics & numerical data

المؤلفون: Hermel DJ; Department of Medicine, The Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases., Nael A; Hematopathology Section, Department of Pathology, University of Southern California, Los Angeles, California, USA., Lu YT; Department of Medicine, The Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases., Kim J; Department of Medicine, The Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases., Brynes RK; Hematopathology Section, Department of Pathology, University of Southern California, Los Angeles, California, USA., Vergara-Lluri M; Hematopathology Section, Department of Pathology, University of Southern California, Los Angeles, California, USA., Akhtari M; Department of Medicine, The Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases.

المصدر: Anti-cancer drugs [Anticancer Drugs] 2019 Apr; Vol. 30 (4), pp. 416-421.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Translocation, Genetic*, Bone Marrow/*pathology , Chromosome Aberrations/*chemically induced , Dasatinib/*adverse effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy, Adult ; Antineoplastic Agents/adverse effects ; Bone Marrow/drug effects ; Chromosomes, Human, Pair 22/genetics ; Chromosomes, Human, Pair 9/genetics ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology ; Male ; Philadelphia Chromosome ; Prognosis